Login to Your Account

AIMM Accelerates Antibody Work with Pharma Partnership

By Nuala Moran
Staff Writer

Monday, November 19, 2012
Dutch start-up AIMM Therapeutics NV has inked a deal with a pharma partner, providing the means to ramp up development of its novel antibody platforms, and has attracted a leading immunologist and former head of the Novartis Institute for Biomedical Research, Jan de Vries, as CEO to spearhead that effort

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription